Article
Distribution of naturally -occurring NS5B resistance-associated substitutions in Egyptian patients with chronic Hepatitis C.
PloS one - 1 Jan 2021
Ahmed Hala Rady, Waly Nancy G F M, Abd El-Baky Rehab Mahmoud, Yahia Ramadan, Hetta Helal F, Elsayed Amr M, Ibrahem Reham Ali
Abstract excerpt
BACKGROUND: NS5B polymerase inhibitors represent the cornerstone of the present treatment of Hepatitis C virus infection (HCV). Naturally occurring substitution mutations to NS5B inhibitors have been recorded. The current study intended to demonstrate possible natural direct acting antiviral (DAA)-mutations of the HCV NS5B region in HCV patients in Minia governorate, Egypt. METHODS: Samples were collected from 27...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
